nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—UGT1A4—Porphyrin metabolism—UROD—head and neck cancer	0.0367	0.17	CbGpPWpGaD
Lamotrigine—UGT1A4—Arylamine metabolism—NAT2—head and neck cancer	0.035	0.163	CbGpPWpGaD
Lamotrigine—UGT1A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00602	0.028	CbGpPWpGaD
Lamotrigine—UGT1A3—Estrogen metabolism—GSTM1—head and neck cancer	0.00597	0.0278	CbGpPWpGaD
Lamotrigine—UGT1A3—Estrogen metabolism—CYP1A1—head and neck cancer	0.00566	0.0263	CbGpPWpGaD
Lamotrigine—UGT1A4—Phase II conjugation—NAT2—head and neck cancer	0.00409	0.019	CbGpPWpGaD
Lamotrigine—UGT1A3—Phase II conjugation—NAT2—head and neck cancer	0.0034	0.0158	CbGpPWpGaD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00322	0.0149	CbGpPWpGaD
Lamotrigine—Amenorrhoea—Docetaxel—head and neck cancer	0.00311	0.00396	CcSEcCtD
Lamotrigine—Dysuria—Hydroxyurea—head and neck cancer	0.00308	0.00393	CcSEcCtD
Lamotrigine—Neutropenia—Hydroxyurea—head and neck cancer	0.00308	0.00393	CcSEcCtD
Lamotrigine—Agranulocytosis—Vinblastine—head and neck cancer	0.00301	0.00383	CcSEcCtD
Lamotrigine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.003	0.00383	CcSEcCtD
Lamotrigine—Weight increased—Hydroxyurea—head and neck cancer	0.003	0.00382	CcSEcCtD
Lamotrigine—Drug interaction—Docetaxel—head and neck cancer	0.00294	0.00375	CcSEcCtD
Lamotrigine—Infestation NOS—Hydroxyurea—head and neck cancer	0.00294	0.00375	CcSEcCtD
Lamotrigine—Drowsiness—Hydroxyurea—head and neck cancer	0.00294	0.00375	CcSEcCtD
Lamotrigine—Infestation—Hydroxyurea—head and neck cancer	0.00294	0.00375	CcSEcCtD
Lamotrigine—Amnesia—Fluorouracil—head and neck cancer	0.00292	0.00372	CcSEcCtD
Lamotrigine—Haemoglobin—Vinblastine—head and neck cancer	0.00291	0.00371	CcSEcCtD
Lamotrigine—Haemorrhage—Vinblastine—head and neck cancer	0.00289	0.00369	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00288	0.00367	CcSEcCtD
Lamotrigine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00288	0.00367	CcSEcCtD
Lamotrigine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00287	0.00366	CcSEcCtD
Lamotrigine—Pharyngitis—Vinblastine—head and neck cancer	0.00287	0.00366	CcSEcCtD
Lamotrigine—Stomatitis—Hydroxyurea—head and neck cancer	0.00287	0.00365	CcSEcCtD
Lamotrigine—Cardiac failure—Fluorouracil—head and neck cancer	0.00281	0.00359	CcSEcCtD
Lamotrigine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00275	0.0035	CcSEcCtD
Lamotrigine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00275	0.0035	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00267	0.0124	CbGpPWpGaD
Lamotrigine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00265	0.00338	CcSEcCtD
Lamotrigine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00264	0.00336	CcSEcCtD
Lamotrigine—Hallucination—Hydroxyurea—head and neck cancer	0.00263	0.00335	CcSEcCtD
Lamotrigine—Irritability—Fluorouracil—head and neck cancer	0.00262	0.00334	CcSEcCtD
Lamotrigine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00261	0.00333	CcSEcCtD
Lamotrigine—Ataxia—Fluorouracil—head and neck cancer	0.00258	0.00329	CcSEcCtD
Lamotrigine—Alopecia—Vinblastine—head and neck cancer	0.00256	0.00326	CcSEcCtD
Lamotrigine—Dry skin—Fluorouracil—head and neck cancer	0.00252	0.00321	CcSEcCtD
Lamotrigine—Oesophagitis—Docetaxel—head and neck cancer	0.0025	0.00318	CcSEcCtD
Lamotrigine—Muscular weakness—Fluorouracil—head and neck cancer	0.00242	0.00309	CcSEcCtD
Lamotrigine—Angiopathy—Hydroxyurea—head and neck cancer	0.0024	0.00305	CcSEcCtD
Lamotrigine—UGT1A4—Biological oxidations—NAT2—head and neck cancer	0.00239	0.0111	CbGpPWpGaD
Lamotrigine—Dysphagia—Fluorouracil—head and neck cancer	0.00237	0.00302	CcSEcCtD
Lamotrigine—Chills—Hydroxyurea—head and neck cancer	0.00237	0.00302	CcSEcCtD
Lamotrigine—UGT1A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00236	0.011	CbGpPWpGaD
Lamotrigine—Eosinophilia—Fluorouracil—head and neck cancer	0.00235	0.00299	CcSEcCtD
Lamotrigine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00234	0.00298	CcSEcCtD
Lamotrigine—Alopecia—Hydroxyurea—head and neck cancer	0.00233	0.00297	CcSEcCtD
Lamotrigine—Anaemia—Vinblastine—head and neck cancer	0.00233	0.00297	CcSEcCtD
Lamotrigine—UGT1A4—NRF2 pathway—TGFA—head and neck cancer	0.00232	0.0108	CbGpPWpGaD
Lamotrigine—Angina pectoris—Fluorouracil—head and neck cancer	0.00231	0.00295	CcSEcCtD
Lamotrigine—Erythema—Hydroxyurea—head and neck cancer	0.0023	0.00293	CcSEcCtD
Lamotrigine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00229	0.00292	CcSEcCtD
Lamotrigine—Malaise—Vinblastine—head and neck cancer	0.00227	0.0029	CcSEcCtD
Lamotrigine—Vertigo—Vinblastine—head and neck cancer	0.00226	0.00288	CcSEcCtD
Lamotrigine—Leukopenia—Vinblastine—head and neck cancer	0.00226	0.00287	CcSEcCtD
Lamotrigine—Pancytopenia—Fluorouracil—head and neck cancer	0.00225	0.00287	CcSEcCtD
Lamotrigine—Deafness—Docetaxel—head and neck cancer	0.00222	0.00282	CcSEcCtD
Lamotrigine—Hepatic failure—Docetaxel—head and neck cancer	0.00221	0.00281	CcSEcCtD
Lamotrigine—Convulsion—Vinblastine—head and neck cancer	0.00218	0.00278	CcSEcCtD
Lamotrigine—Hypertension—Vinblastine—head and neck cancer	0.00218	0.00277	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00217	0.00276	CcSEcCtD
Lamotrigine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00213	0.00272	CcSEcCtD
Lamotrigine—Pneumonia—Fluorouracil—head and neck cancer	0.00213	0.00271	CcSEcCtD
Lamotrigine—Anaemia—Hydroxyurea—head and neck cancer	0.00212	0.00271	CcSEcCtD
Lamotrigine—Discomfort—Vinblastine—head and neck cancer	0.00212	0.0027	CcSEcCtD
Lamotrigine—Hot flush—Docetaxel—head and neck cancer	0.00212	0.0027	CcSEcCtD
Lamotrigine—Infestation—Fluorouracil—head and neck cancer	0.00212	0.0027	CcSEcCtD
Lamotrigine—Infestation NOS—Fluorouracil—head and neck cancer	0.00212	0.0027	CcSEcCtD
Lamotrigine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00211	0.0098	CbGpPWpGaD
Lamotrigine—Menopausal symptoms—Docetaxel—head and neck cancer	0.0021	0.00268	CcSEcCtD
Lamotrigine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00209	0.00267	CcSEcCtD
Lamotrigine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00209	0.00266	CcSEcCtD
Lamotrigine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00207	0.00264	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00207	0.00264	CcSEcCtD
Lamotrigine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00207	0.00264	CcSEcCtD
Lamotrigine—Malaise—Hydroxyurea—head and neck cancer	0.00207	0.00264	CcSEcCtD
Lamotrigine—Stomatitis—Fluorouracil—head and neck cancer	0.00206	0.00263	CcSEcCtD
Lamotrigine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00206	0.00262	CcSEcCtD
Lamotrigine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00206	0.00262	CcSEcCtD
Lamotrigine—Leukopenia—Hydroxyurea—head and neck cancer	0.00206	0.00262	CcSEcCtD
Lamotrigine—Cardiac failure—Docetaxel—head and neck cancer	0.00203	0.00259	CcSEcCtD
Lamotrigine—UGT1A4—Phase II conjugation—GSTM1—head and neck cancer	0.00202	0.00938	CbGpPWpGaD
Lamotrigine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00201	0.00257	CcSEcCtD
Lamotrigine—Epistaxis—Fluorouracil—head and neck cancer	0.002	0.00254	CcSEcCtD
Lamotrigine—Convulsion—Hydroxyurea—head and neck cancer	0.00199	0.00254	CcSEcCtD
Lamotrigine—UGT1A3—Biological oxidations—NAT2—head and neck cancer	0.00199	0.00924	CbGpPWpGaD
Lamotrigine—Sinusitis—Fluorouracil—head and neck cancer	0.00199	0.00253	CcSEcCtD
Lamotrigine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00198	0.00253	CcSEcCtD
Lamotrigine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00198	0.00252	CcSEcCtD
Lamotrigine—UGT1A3—Metapathway biotransformation—NAT2—head and neck cancer	0.00196	0.00911	CbGpPWpGaD
Lamotrigine—Anorexia—Vinblastine—head and neck cancer	0.00196	0.0025	CcSEcCtD
Lamotrigine—Migraine—Docetaxel—head and neck cancer	0.00195	0.00249	CcSEcCtD
Lamotrigine—Discomfort—Hydroxyurea—head and neck cancer	0.00193	0.00246	CcSEcCtD
Lamotrigine—UGT1A3—NRF2 pathway—TGFA—head and neck cancer	0.00193	0.00895	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CEBPA—head and neck cancer	0.00191	0.00889	CbGpPWpGaD
Lamotrigine—Haemoglobin—Fluorouracil—head and neck cancer	0.00191	0.00243	CcSEcCtD
Lamotrigine—Rhinitis—Fluorouracil—head and neck cancer	0.0019	0.00243	CcSEcCtD
Lamotrigine—Haemorrhage—Fluorouracil—head and neck cancer	0.0019	0.00242	CcSEcCtD
Lamotrigine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00189	0.00241	CcSEcCtD
Lamotrigine—Pharyngitis—Fluorouracil—head and neck cancer	0.00189	0.0024	CcSEcCtD
Lamotrigine—Oedema—Hydroxyurea—head and neck cancer	0.00188	0.00239	CcSEcCtD
Lamotrigine—Ataxia—Docetaxel—head and neck cancer	0.00186	0.00238	CcSEcCtD
Lamotrigine—Infection—Hydroxyurea—head and neck cancer	0.00186	0.00237	CcSEcCtD
Lamotrigine—Paraesthesia—Vinblastine—head and neck cancer	0.00185	0.00235	CcSEcCtD
Lamotrigine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00184	0.00234	CcSEcCtD
Lamotrigine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00184	0.00234	CcSEcCtD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—head and neck cancer	0.00183	0.00852	CbGpPWpGaD
Lamotrigine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00183	0.00233	CcSEcCtD
Lamotrigine—Dry skin—Docetaxel—head and neck cancer	0.00182	0.00232	CcSEcCtD
Lamotrigine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00181	0.00231	CcSEcCtD
Lamotrigine—Anorexia—Hydroxyurea—head and neck cancer	0.00179	0.00228	CcSEcCtD
Lamotrigine—Decreased appetite—Vinblastine—head and neck cancer	0.00179	0.00228	CcSEcCtD
Lamotrigine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00179	0.00227	CcSEcCtD
Lamotrigine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00179	0.00227	CcSEcCtD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00177	0.00824	CbGpPWpGaD
Lamotrigine—Pain—Vinblastine—head and neck cancer	0.00176	0.00224	CcSEcCtD
Lamotrigine—Constipation—Vinblastine—head and neck cancer	0.00176	0.00224	CcSEcCtD
Lamotrigine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00175	0.00223	CcSEcCtD
Lamotrigine—Dysphagia—Docetaxel—head and neck cancer	0.00171	0.00218	CcSEcCtD
Lamotrigine—Feeling abnormal—Vinblastine—head and neck cancer	0.00169	0.00216	CcSEcCtD
Lamotrigine—Bronchospasm—Docetaxel—head and neck cancer	0.00169	0.00215	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00168	0.00214	CcSEcCtD
Lamotrigine—Alopecia—Fluorouracil—head and neck cancer	0.00168	0.00214	CcSEcCtD
Lamotrigine—UGT1A3—Phase II conjugation—GSTM1—head and neck cancer	0.00168	0.0078	CbGpPWpGaD
Lamotrigine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00167	0.00213	CcSEcCtD
Lamotrigine—Angina pectoris—Docetaxel—head and neck cancer	0.00167	0.00213	CcSEcCtD
Lamotrigine—Somnolence—Hydroxyurea—head and neck cancer	0.00167	0.00212	CcSEcCtD
Lamotrigine—Erythema—Fluorouracil—head and neck cancer	0.00165	0.00211	CcSEcCtD
Lamotrigine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00165	0.0021	CcSEcCtD
Lamotrigine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00163	0.00208	CcSEcCtD
Lamotrigine—Pancytopenia—Docetaxel—head and neck cancer	0.00163	0.00207	CcSEcCtD
Lamotrigine—Abdominal pain—Vinblastine—head and neck cancer	0.00163	0.00207	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00162	0.00206	CcSEcCtD
Lamotrigine—Fatigue—Hydroxyurea—head and neck cancer	0.00162	0.00206	CcSEcCtD
Lamotrigine—Constipation—Hydroxyurea—head and neck cancer	0.0016	0.00204	CcSEcCtD
Lamotrigine—Pain—Hydroxyurea—head and neck cancer	0.0016	0.00204	CcSEcCtD
Lamotrigine—Neutropenia—Docetaxel—head and neck cancer	0.0016	0.00204	CcSEcCtD
Lamotrigine—Weight increased—Docetaxel—head and neck cancer	0.00156	0.00199	CcSEcCtD
Lamotrigine—Vision blurred—Fluorouracil—head and neck cancer	0.00156	0.00199	CcSEcCtD
Lamotrigine—Weight decreased—Docetaxel—head and neck cancer	0.00155	0.00198	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—CEBPA—head and neck cancer	0.00155	0.00719	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00155	0.00197	CcSEcCtD
Lamotrigine—Pneumonia—Docetaxel—head and neck cancer	0.00154	0.00196	CcSEcCtD
Lamotrigine—Anaemia—Fluorouracil—head and neck cancer	0.00153	0.00195	CcSEcCtD
Lamotrigine—Infestation—Docetaxel—head and neck cancer	0.00153	0.00195	CcSEcCtD
Lamotrigine—Infestation NOS—Docetaxel—head and neck cancer	0.00153	0.00195	CcSEcCtD
Lamotrigine—Hypersensitivity—Vinblastine—head and neck cancer	0.00152	0.00193	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00151	0.00193	CcSEcCtD
Lamotrigine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00151	0.00192	CcSEcCtD
Lamotrigine—Renal failure—Docetaxel—head and neck cancer	0.0015	0.00191	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0015	0.00191	CcSEcCtD
Lamotrigine—Myocardial infarction—Docetaxel—head and neck cancer	0.0015	0.00191	CcSEcCtD
Lamotrigine—Stomatitis—Docetaxel—head and neck cancer	0.00149	0.0019	CcSEcCtD
Lamotrigine—Conjunctivitis—Docetaxel—head and neck cancer	0.00148	0.00189	CcSEcCtD
Lamotrigine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00148	0.00189	CcSEcCtD
Lamotrigine—Leukopenia—Fluorouracil—head and neck cancer	0.00148	0.00189	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—CEBPA—head and neck cancer	0.00148	0.00688	CbGpPWpGaD
Lamotrigine—Asthenia—Vinblastine—head and neck cancer	0.00148	0.00188	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00147	0.00685	CbGpPWpGaD
Lamotrigine—Epistaxis—Docetaxel—head and neck cancer	0.00144	0.00184	CcSEcCtD
Lamotrigine—Convulsion—Fluorouracil—head and neck cancer	0.00143	0.00183	CcSEcCtD
Lamotrigine—Agranulocytosis—Docetaxel—head and neck cancer	0.00143	0.00182	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—CEBPA—head and neck cancer	0.00142	0.00661	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CEBPA—head and neck cancer	0.00142	0.00661	CbGpPWpGaD
Lamotrigine—Chest pain—Fluorouracil—head and neck cancer	0.00141	0.00179	CcSEcCtD
Lamotrigine—Myalgia—Fluorouracil—head and neck cancer	0.00141	0.00179	CcSEcCtD
Lamotrigine—Diarrhoea—Vinblastine—head and neck cancer	0.00141	0.00179	CcSEcCtD
Lamotrigine—Discomfort—Fluorouracil—head and neck cancer	0.00139	0.00177	CcSEcCtD
Lamotrigine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00138	0.00176	CcSEcCtD
Lamotrigine—Haemoglobin—Docetaxel—head and neck cancer	0.00138	0.00176	CcSEcCtD
Lamotrigine—Rhinitis—Docetaxel—head and neck cancer	0.00137	0.00175	CcSEcCtD
Lamotrigine—Hepatitis—Docetaxel—head and neck cancer	0.00137	0.00175	CcSEcCtD
Lamotrigine—Haemorrhage—Docetaxel—head and neck cancer	0.00137	0.00175	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—CEBPA—head and neck cancer	0.00137	0.00637	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CEBPA—head and neck cancer	0.00137	0.00637	CbGpPWpGaD
Lamotrigine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00136	0.00174	CcSEcCtD
Lamotrigine—Confusional state—Fluorouracil—head and neck cancer	0.00136	0.00173	CcSEcCtD
Lamotrigine—Pharyngitis—Docetaxel—head and neck cancer	0.00136	0.00173	CcSEcCtD
Lamotrigine—Dizziness—Vinblastine—head and neck cancer	0.00136	0.00173	CcSEcCtD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00136	0.0063	CbGpPWpGaD
Lamotrigine—Oedema peripheral—Docetaxel—head and neck cancer	0.00135	0.00172	CcSEcCtD
Lamotrigine—Oedema—Fluorouracil—head and neck cancer	0.00135	0.00172	CcSEcCtD
Lamotrigine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00135	0.00172	CcSEcCtD
Lamotrigine—UGT1A4—NRF2 pathway—GSTM1—head and neck cancer	0.00135	0.00626	CbGpPWpGaD
Lamotrigine—Asthenia—Hydroxyurea—head and neck cancer	0.00135	0.00171	CcSEcCtD
Lamotrigine—Infection—Fluorouracil—head and neck cancer	0.00134	0.00171	CcSEcCtD
Lamotrigine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00132	0.00169	CcSEcCtD
Lamotrigine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00132	0.00168	CcSEcCtD
Lamotrigine—Tachycardia—Fluorouracil—head and neck cancer	0.00132	0.00168	CcSEcCtD
Lamotrigine—Vomiting—Vinblastine—head and neck cancer	0.00131	0.00167	CcSEcCtD
Lamotrigine—Erythema multiforme—Docetaxel—head and neck cancer	0.0013	0.00165	CcSEcCtD
Lamotrigine—Headache—Vinblastine—head and neck cancer	0.00129	0.00164	CcSEcCtD
Lamotrigine—Anorexia—Fluorouracil—head and neck cancer	0.00129	0.00164	CcSEcCtD
Lamotrigine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00128	0.00164	CcSEcCtD
Lamotrigine—Eye disorder—Docetaxel—head and neck cancer	0.00128	0.00163	CcSEcCtD
Lamotrigine—Flushing—Docetaxel—head and neck cancer	0.00127	0.00162	CcSEcCtD
Lamotrigine—SCN8A—L1CAM interactions—MAPK3—head and neck cancer	0.00125	0.00582	CbGpPWpGaD
Lamotrigine—Angiopathy—Docetaxel—head and neck cancer	0.00124	0.00159	CcSEcCtD
Lamotrigine—Dizziness—Hydroxyurea—head and neck cancer	0.00124	0.00158	CcSEcCtD
Lamotrigine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00124	0.00157	CcSEcCtD
Lamotrigine—Chills—Docetaxel—head and neck cancer	0.00123	0.00157	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00123	0.00157	CcSEcCtD
Lamotrigine—Nausea—Vinblastine—head and neck cancer	0.00122	0.00156	CcSEcCtD
Lamotrigine—Insomnia—Fluorouracil—head and neck cancer	0.00122	0.00156	CcSEcCtD
Lamotrigine—Paraesthesia—Fluorouracil—head and neck cancer	0.00121	0.00154	CcSEcCtD
Lamotrigine—Alopecia—Docetaxel—head and neck cancer	0.00121	0.00154	CcSEcCtD
Lamotrigine—Dyspnoea—Fluorouracil—head and neck cancer	0.0012	0.00153	CcSEcCtD
Lamotrigine—Mental disorder—Docetaxel—head and neck cancer	0.0012	0.00153	CcSEcCtD
Lamotrigine—Somnolence—Fluorouracil—head and neck cancer	0.0012	0.00153	CcSEcCtD
Lamotrigine—Malnutrition—Docetaxel—head and neck cancer	0.00119	0.00152	CcSEcCtD
Lamotrigine—Erythema—Docetaxel—head and neck cancer	0.00119	0.00152	CcSEcCtD
Lamotrigine—Vomiting—Hydroxyurea—head and neck cancer	0.00119	0.00152	CcSEcCtD
Lamotrigine—SCN8A—L1CAM interactions—MAPK1—head and neck cancer	0.00119	0.00554	CbGpPWpGaD
Lamotrigine—SCN8A—L1CAM interactions—EGFR—head and neck cancer	0.00119	0.00553	CbGpPWpGaD
Lamotrigine—Dyspepsia—Fluorouracil—head and neck cancer	0.00119	0.00151	CcSEcCtD
Lamotrigine—Rash—Hydroxyurea—head and neck cancer	0.00118	0.00151	CcSEcCtD
Lamotrigine—Dermatitis—Hydroxyurea—head and neck cancer	0.00118	0.00151	CcSEcCtD
Lamotrigine—UGT1A4—Biological oxidations—GSTM1—head and neck cancer	0.00118	0.00549	CbGpPWpGaD
Lamotrigine—Headache—Hydroxyurea—head and neck cancer	0.00117	0.0015	CcSEcCtD
Lamotrigine—Decreased appetite—Fluorouracil—head and neck cancer	0.00117	0.0015	CcSEcCtD
Lamotrigine—Dysgeusia—Docetaxel—head and neck cancer	0.00117	0.00149	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00117	0.00149	CcSEcCtD
Lamotrigine—UGT1A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.00116	0.00541	CbGpPWpGaD
Lamotrigine—Back pain—Docetaxel—head and neck cancer	0.00115	0.00147	CcSEcCtD
Lamotrigine—Pain—Fluorouracil—head and neck cancer	0.00115	0.00147	CcSEcCtD
Lamotrigine—Muscle spasms—Docetaxel—head and neck cancer	0.00115	0.00146	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00113	0.00524	CbGpPWpGaD
Lamotrigine—UGT1A4—Biological oxidations—CYP1A1—head and neck cancer	0.00112	0.0052	CbGpPWpGaD
Lamotrigine—UGT1A3—NRF2 pathway—GSTM1—head and neck cancer	0.00112	0.0052	CbGpPWpGaD
Lamotrigine—Nausea—Hydroxyurea—head and neck cancer	0.00111	0.00142	CcSEcCtD
Lamotrigine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00111	0.00142	CcSEcCtD
Lamotrigine—UGT1A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.0011	0.00513	CbGpPWpGaD
Lamotrigine—Anaemia—Docetaxel—head and neck cancer	0.0011	0.00141	CcSEcCtD
Lamotrigine—Urticaria—Fluorouracil—head and neck cancer	0.00107	0.00137	CcSEcCtD
Lamotrigine—Syncope—Docetaxel—head and neck cancer	0.00107	0.00136	CcSEcCtD
Lamotrigine—Leukopenia—Docetaxel—head and neck cancer	0.00107	0.00136	CcSEcCtD
Lamotrigine—Body temperature increased—Fluorouracil—head and neck cancer	0.00107	0.00136	CcSEcCtD
Lamotrigine—Palpitations—Docetaxel—head and neck cancer	0.00106	0.00134	CcSEcCtD
Lamotrigine—Loss of consciousness—Docetaxel—head and neck cancer	0.00105	0.00134	CcSEcCtD
Lamotrigine—Cough—Docetaxel—head and neck cancer	0.00104	0.00133	CcSEcCtD
Lamotrigine—Convulsion—Docetaxel—head and neck cancer	0.00103	0.00132	CcSEcCtD
Lamotrigine—Hypertension—Docetaxel—head and neck cancer	0.00103	0.00131	CcSEcCtD
Lamotrigine—Myalgia—Docetaxel—head and neck cancer	0.00102	0.0013	CcSEcCtD
Lamotrigine—Arthralgia—Docetaxel—head and neck cancer	0.00102	0.0013	CcSEcCtD
Lamotrigine—Chest pain—Docetaxel—head and neck cancer	0.00102	0.0013	CcSEcCtD
Lamotrigine—SCN9A—L1CAM interactions—MAPK3—head and neck cancer	0.00101	0.0047	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000995	0.00127	CcSEcCtD
Lamotrigine—Dry mouth—Docetaxel—head and neck cancer	0.000994	0.00127	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—UROD—head and neck cancer	0.000985	0.00458	CbGpPWpGaD
Lamotrigine—Confusional state—Docetaxel—head and neck cancer	0.000982	0.00125	CcSEcCtD
Lamotrigine—UGT1A3—Biological oxidations—GSTM1—head and neck cancer	0.000982	0.00456	CbGpPWpGaD
Lamotrigine—Oedema—Docetaxel—head and neck cancer	0.000974	0.00124	CcSEcCtD
Lamotrigine—SCN3A—L1CAM interactions—MAPK3—head and neck cancer	0.000968	0.0045	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—GSTM1—head and neck cancer	0.000968	0.0045	CbGpPWpGaD
Lamotrigine—Infection—Docetaxel—head and neck cancer	0.000968	0.00123	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—CEBPA—head and neck cancer	0.000964	0.00448	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—MAPK1—head and neck cancer	0.000963	0.00448	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—EGFR—head and neck cancer	0.000963	0.00448	CbGpPWpGaD
Lamotrigine—Shock—Docetaxel—head and neck cancer	0.000959	0.00122	CcSEcCtD
Lamotrigine—Nervous system disorder—Docetaxel—head and neck cancer	0.000956	0.00122	CcSEcCtD
Lamotrigine—Pruritus—Fluorouracil—head and neck cancer	0.000955	0.00122	CcSEcCtD
Lamotrigine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000954	0.00122	CcSEcCtD
Lamotrigine—Tachycardia—Docetaxel—head and neck cancer	0.000951	0.00121	CcSEcCtD
Lamotrigine—UGT1A3—Biological oxidations—CYP1A1—head and neck cancer	0.000931	0.00432	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—MAPK3—head and neck cancer	0.00093	0.00432	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—MAPK3—head and neck cancer	0.00093	0.00432	CbGpPWpGaD
Lamotrigine—Anorexia—Docetaxel—head and neck cancer	0.000929	0.00118	CcSEcCtD
Lamotrigine—Diarrhoea—Fluorouracil—head and neck cancer	0.000924	0.00118	CcSEcCtD
Lamotrigine—SCN3A—L1CAM interactions—MAPK1—head and neck cancer	0.000921	0.00428	CbGpPWpGaD
Lamotrigine—SCN3A—L1CAM interactions—EGFR—head and neck cancer	0.000921	0.00428	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000918	0.00427	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—MAPK3—head and neck cancer	0.000897	0.00417	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—MAPK3—head and neck cancer	0.000897	0.00417	CbGpPWpGaD
Lamotrigine—Dizziness—Fluorouracil—head and neck cancer	0.000893	0.00114	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000888	0.00113	CcSEcCtD
Lamotrigine—SCN2A—L1CAM interactions—MAPK1—head and neck cancer	0.000885	0.00411	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—MAPK1—head and neck cancer	0.000885	0.00411	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—EGFR—head and neck cancer	0.000885	0.00411	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—EGFR—head and neck cancer	0.000885	0.00411	CbGpPWpGaD
Lamotrigine—Insomnia—Docetaxel—head and neck cancer	0.000881	0.00112	CcSEcCtD
Lamotrigine—Paraesthesia—Docetaxel—head and neck cancer	0.000875	0.00111	CcSEcCtD
Lamotrigine—Dyspnoea—Docetaxel—head and neck cancer	0.000869	0.00111	CcSEcCtD
Lamotrigine—Somnolence—Docetaxel—head and neck cancer	0.000866	0.0011	CcSEcCtD
Lamotrigine—Vomiting—Fluorouracil—head and neck cancer	0.000858	0.00109	CcSEcCtD
Lamotrigine—Dyspepsia—Docetaxel—head and neck cancer	0.000858	0.00109	CcSEcCtD
Lamotrigine—SCN1A—L1CAM interactions—MAPK1—head and neck cancer	0.000854	0.00397	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—MAPK1—head and neck cancer	0.000854	0.00397	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—EGFR—head and neck cancer	0.000853	0.00397	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—EGFR—head and neck cancer	0.000853	0.00397	CbGpPWpGaD
Lamotrigine—Rash—Fluorouracil—head and neck cancer	0.000851	0.00108	CcSEcCtD
Lamotrigine—Dermatitis—Fluorouracil—head and neck cancer	0.00085	0.00108	CcSEcCtD
Lamotrigine—Decreased appetite—Docetaxel—head and neck cancer	0.000847	0.00108	CcSEcCtD
Lamotrigine—Headache—Fluorouracil—head and neck cancer	0.000846	0.00108	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000841	0.00107	CcSEcCtD
Lamotrigine—Fatigue—Docetaxel—head and neck cancer	0.00084	0.00107	CcSEcCtD
Lamotrigine—Pain—Docetaxel—head and neck cancer	0.000833	0.00106	CcSEcCtD
Lamotrigine—Constipation—Docetaxel—head and neck cancer	0.000833	0.00106	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—UROD—head and neck cancer	0.000819	0.0038	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Docetaxel—head and neck cancer	0.000803	0.00102	CcSEcCtD
Lamotrigine—Nausea—Fluorouracil—head and neck cancer	0.000802	0.00102	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000797	0.00102	CcSEcCtD
Lamotrigine—Abdominal pain—Docetaxel—head and neck cancer	0.00077	0.000981	CcSEcCtD
Lamotrigine—Body temperature increased—Docetaxel—head and neck cancer	0.00077	0.000981	CcSEcCtD
Lamotrigine—Hypersensitivity—Docetaxel—head and neck cancer	0.000718	0.000915	CcSEcCtD
Lamotrigine—Asthenia—Docetaxel—head and neck cancer	0.000699	0.000891	CcSEcCtD
Lamotrigine—Pruritus—Docetaxel—head and neck cancer	0.000689	0.000878	CcSEcCtD
Lamotrigine—Diarrhoea—Docetaxel—head and neck cancer	0.000667	0.000849	CcSEcCtD
Lamotrigine—Dizziness—Docetaxel—head and neck cancer	0.000644	0.000821	CcSEcCtD
Lamotrigine—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.000631	0.00293	CbGpPWpGaD
Lamotrigine—Vomiting—Docetaxel—head and neck cancer	0.000619	0.000789	CcSEcCtD
Lamotrigine—Rash—Docetaxel—head and neck cancer	0.000614	0.000783	CcSEcCtD
Lamotrigine—Dermatitis—Docetaxel—head and neck cancer	0.000614	0.000782	CcSEcCtD
Lamotrigine—Headache—Docetaxel—head and neck cancer	0.00061	0.000778	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—NOTCH1—head and neck cancer	0.00061	0.00284	CbGpPWpGaD
Lamotrigine—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.0006	0.00279	CbGpPWpGaD
Lamotrigine—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.0006	0.00279	CbGpPWpGaD
Lamotrigine—Nausea—Docetaxel—head and neck cancer	0.000579	0.000737	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00053	0.00246	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—VEGFA—head and neck cancer	0.0005	0.00232	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—NOTCH1—head and neck cancer	0.000493	0.00229	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000482	0.00224	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—MAPK3—head and neck cancer	0.000473	0.0022	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—NOTCH1—head and neck cancer	0.000472	0.00219	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—NOTCH1—head and neck cancer	0.000453	0.00211	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—NOTCH1—head and neck cancer	0.000453	0.00211	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000452	0.0021	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—MAPK1—head and neck cancer	0.00045	0.00209	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—EGFR—head and neck cancer	0.00045	0.00209	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—NOTCH1—head and neck cancer	0.000437	0.00203	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—NOTCH1—head and neck cancer	0.000437	0.00203	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—NAT2—head and neck cancer	0.000409	0.0019	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—VEGFA—head and neck cancer	0.000404	0.00188	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000401	0.00186	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—VEGFA—head and neck cancer	0.000387	0.0018	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MAPK3—head and neck cancer	0.000383	0.00178	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—VEGFA—head and neck cancer	0.000372	0.00173	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—VEGFA—head and neck cancer	0.000372	0.00173	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MAPK3—head and neck cancer	0.000366	0.0017	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MAPK1—head and neck cancer	0.000364	0.00169	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—EGFR—head and neck cancer	0.000364	0.00169	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—HRAS—head and neck cancer	0.000361	0.00168	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—DPYD—head and neck cancer	0.000359	0.00167	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—VEGFA—head and neck cancer	0.000358	0.00167	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—VEGFA—head and neck cancer	0.000358	0.00167	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—VEGFA—head and neck cancer	0.000357	0.00166	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—STAT3—head and neck cancer	0.000353	0.00164	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MAPK3—head and neck cancer	0.000352	0.00163	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MAPK3—head and neck cancer	0.000352	0.00163	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MAPK1—head and neck cancer	0.000348	0.00162	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—EGFR—head and neck cancer	0.000348	0.00162	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—YAP1—head and neck cancer	0.00034	0.00158	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—NAT2—head and neck cancer	0.00034	0.00158	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MAPK3—head and neck cancer	0.000339	0.00158	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MAPK3—head and neck cancer	0.000339	0.00158	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MAPK3—head and neck cancer	0.000338	0.00157	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MAPK1—head and neck cancer	0.000335	0.00155	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MAPK1—head and neck cancer	0.000335	0.00155	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—EGFR—head and neck cancer	0.000334	0.00155	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—EGFR—head and neck cancer	0.000334	0.00155	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MAPK1—head and neck cancer	0.000323	0.0015	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MAPK1—head and neck cancer	0.000323	0.0015	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—EGFR—head and neck cancer	0.000323	0.0015	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—EGFR—head and neck cancer	0.000323	0.0015	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MAPK1—head and neck cancer	0.000321	0.00149	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—EGFR—head and neck cancer	0.000321	0.00149	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	0.000307	0.00143	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000303	0.00141	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—DPYD—head and neck cancer	0.000298	0.00139	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000297	0.00138	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—HRAS—head and neck cancer	0.000292	0.00136	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000291	0.00135	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00029	0.00135	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—VEGFA—head and neck cancer	0.000289	0.00134	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—STAT3—head and neck cancer	0.000286	0.00133	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—YAP1—head and neck cancer	0.000283	0.00131	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—HRAS—head and neck cancer	0.00028	0.0013	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—VEGFA—head and neck cancer	0.000276	0.00128	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—STAT3—head and neck cancer	0.000273	0.00127	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MAPK3—head and neck cancer	0.000273	0.00127	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—HRAS—head and neck cancer	0.000269	0.00125	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—HRAS—head and neck cancer	0.000269	0.00125	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—VEGFA—head and neck cancer	0.000265	0.00123	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—VEGFA—head and neck cancer	0.000265	0.00123	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—STAT3—head and neck cancer	0.000263	0.00122	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—STAT3—head and neck cancer	0.000263	0.00122	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MAPK3—head and neck cancer	0.000261	0.00121	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MAPK1—head and neck cancer	0.00026	0.00121	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EGFR—head and neck cancer	0.00026	0.00121	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—UROD—head and neck cancer	0.000259	0.00121	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—HRAS—head and neck cancer	0.000259	0.0012	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—HRAS—head and neck cancer	0.000259	0.0012	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—HRAS—head and neck cancer	0.000258	0.0012	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000258	0.0012	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—VEGFA—head and neck cancer	0.000256	0.00119	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—VEGFA—head and neck cancer	0.000256	0.00119	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—STAT3—head and neck cancer	0.000253	0.00118	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—STAT3—head and neck cancer	0.000253	0.00118	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—VEGFA—head and neck cancer	0.000252	0.00117	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MAPK3—head and neck cancer	0.000251	0.00117	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MAPK3—head and neck cancer	0.000251	0.00117	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MAPK1—head and neck cancer	0.000248	0.00115	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EGFR—head and neck cancer	0.000248	0.00115	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MAPK3—head and neck cancer	0.000242	0.00112	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MAPK3—head and neck cancer	0.000242	0.00112	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MAPK1—head and neck cancer	0.000239	0.00111	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MAPK1—head and neck cancer	0.000239	0.00111	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EGFR—head and neck cancer	0.000239	0.00111	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EGFR—head and neck cancer	0.000239	0.00111	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MAPK3—head and neck cancer	0.000238	0.00111	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MAPK1—head and neck cancer	0.00023	0.00107	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MAPK1—head and neck cancer	0.00023	0.00107	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EGFR—head and neck cancer	0.00023	0.00107	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EGFR—head and neck cancer	0.00023	0.00107	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—AKT1—head and neck cancer	0.000228	0.00106	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MAPK1—head and neck cancer	0.000227	0.00105	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—EGFR—head and neck cancer	0.000227	0.00105	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—HRAS—head and neck cancer	0.000209	0.000969	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—TYMS—head and neck cancer	0.000204	0.00095	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GSTM1—head and neck cancer	0.000202	0.000939	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—HRAS—head and neck cancer	0.000199	0.000927	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000198	0.00092	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GPX1—head and neck cancer	0.000193	0.000899	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—HRAS—head and neck cancer	0.000192	0.000891	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HRAS—head and neck cancer	0.000192	0.000891	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CYP1A1—head and neck cancer	0.000191	0.00089	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.00019	0.000882	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—HRAS—head and neck cancer	0.000185	0.000859	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HRAS—head and neck cancer	0.000185	0.000859	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—AKT1—head and neck cancer	0.000184	0.000856	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—HRAS—head and neck cancer	0.000182	0.000846	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—VEGFA—head and neck cancer	0.00018	0.000836	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—STAT3—head and neck cancer	0.000178	0.000827	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—AKT1—head and neck cancer	0.000176	0.000819	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MAPK3—head and neck cancer	0.00017	0.00079	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—TYMS—head and neck cancer	0.00017	0.000789	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.00017	0.000789	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—AKT1—head and neck cancer	0.000169	0.000786	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—AKT1—head and neck cancer	0.000169	0.000786	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GSTM1—head and neck cancer	0.000168	0.00078	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—AKT1—head and neck cancer	0.000163	0.000758	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—AKT1—head and neck cancer	0.000163	0.000758	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MAPK1—head and neck cancer	0.000162	0.000752	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EGFR—head and neck cancer	0.000162	0.000752	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000161	0.00075	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GPX1—head and neck cancer	0.000161	0.000747	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CYP1A1—head and neck cancer	0.000159	0.00074	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000146	0.000677	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000141	0.000654	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—HRAS—head and neck cancer	0.00013	0.000604	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000127	0.000591	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00012	0.000559	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—AKT1—head and neck cancer	0.000115	0.000533	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000114	0.000532	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000114	0.000531	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTGS2—head and neck cancer	0.000114	0.000529	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NAT2—head and neck cancer	0.000108	0.000501	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTEN—head and neck cancer	9.93e-05	0.000461	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.93e-05	0.000461	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.6e-05	0.000446	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTGS2—head and neck cancer	9.47e-05	0.00044	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—DPYD—head and neck cancer	9.45e-05	0.000439	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—YAP1—head and neck cancer	8.97e-05	0.000417	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTEN—head and neck cancer	8.25e-05	0.000384	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.11e-05	0.000377	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PIK3CA—head and neck cancer	7.01e-05	0.000326	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PIK3CA—head and neck cancer	5.82e-05	0.000271	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AKT1—head and neck cancer	5.72e-05	0.000266	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—TYMS—head and neck cancer	5.38e-05	0.00025	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTM1—head and neck cancer	5.32e-05	0.000247	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GPX1—head and neck cancer	5.1e-05	0.000237	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.04e-05	0.000234	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKT1—head and neck cancer	4.76e-05	0.000221	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTGS2—head and neck cancer	3e-05	0.000139	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTEN—head and neck cancer	2.62e-05	0.000122	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.85e-05	8.58e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKT1—head and neck cancer	1.51e-05	7.01e-05	CbGpPWpGaD
